Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nitric Oxide Patch vs Meglumine Antimoniate for Cutaneous Leishmaniasis
NCT00317629Phase 3Terminated
- Sponsor
- Fundación Cardiovascular de Colombia
- Start
- May 2006
- Primary completion
- Jan 2009
- Modality
- Small Molecules, Device-based Delivery
- Countries
- 1
01
Overview
A Phase 3 trial of Nitric oxide patch (Fundación Cardiovascular de Colombia) in cutaneous leishmaniasis (CL), sponsored by Fundación Cardiovascular de Colombia. Started May 2006; status: terminated.
02
Drugs
Nitric oxide patch (Fundación Cardiovascular de Colombia)
03
Conditions
cutaneous leishmaniasis (CL)
Beyond the preview
Go deeper on NCT00317629.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00317629.